ARCHIVES

FDA Says Medicare Policy On ESAs “Consistent With The Available Data.”

This article is from The Cancer Letter archive.

Vol. 33 No. 38 | October 19, 2007

Download PDF Visit The Full Archive

Related Articles

ASCO Board Accepts Plan To Establish New Bethesda Headquarters, Hire Chief Officer

April 23, 1993

California Weighs Listing Tamoxifen As Carcinogen

October 27, 1995

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

March 25, 2011

DCT Issues Two Pas for Small/Exploratory Grants For Clinical, Laboratory Studies

March 23, 1994

In Brief: Hospices Urges To Develop Program For AIDs Victims; Companies Give $25,5000 To NCI Fund

October 25, 1985

MicroRNA Assay Detects Cancer Two Years Before LDCT in Study

January 31, 2014